首页> 外文期刊>Toxicon: An International Journal Devoted to the Exchange of Knowledge on the Poisons Derived from Animals, Plants and Microorganisms >Pharmacokinetics of tetrodotoxin in puffer fish Takifugu rubripes by a single administration technique.
【24h】

Pharmacokinetics of tetrodotoxin in puffer fish Takifugu rubripes by a single administration technique.

机译:河豚毒素在河豚鱼中的药代动力学通过单一施用技术。

获取原文
获取原文并翻译 | 示例
       

摘要

Marine puffer fish accumulates tetrodotoxin (TTX) in the liver and ovary. In this study, we examined the pharmacokinetics of TTX in Takifugu rubripes by a single administration under general anesthesia at 20 degrees C for 300min. The blood concentration-time profile showed multiple distinct phases after injection into hepatic portal vein. The area under the blood concentration-time curve (AUC) increased linearly at the dosage of 0.25-0.75mgTTX/kg body weight, and the total body clearance was 2.06+/-0.17mL/min/kg body weight. The AUCs following administration into the hepatic portal vein and hepatic vein were closely similar (147+/-33 versus 141+/-1ng.min/muL), indicating negligible hepatic first-pass effect. Comparison of the AUCs following an administration to the hepatic vein and gastrointestinal tract (0.25mgTTX/kg body weight) elucidated the bioavailability of TTX to be 62%. There was no significant increase in the AUCs following direct injection into the gastrointestinal tract (0.50 versus 1.0mgTTX/kg body weight). At the dosage of 0.25mgTTX/kg body weight into the hepatic vein, hepatic portal vein or gastrointestinal tract, TTX amount in the liver accounted for 84+/-6%, 70+/-9% or 49+/-17% of the total TTX amount applied, respectively. These results demonstrate that TTX is absorbed into the systemic circulation from the gastrointestinal tract by saturable mechanism and finally accumulated in the liver within 300min.
机译:海洋河豚鱼在肝脏和卵巢中积累了河豚毒素(TTX)。在这项研究中,我们通过全身麻醉在20摄氏度下300分钟单次给药,研究了Takifugu rubripes中TTX的药代动力学。注入肝门静脉后,血药浓度-时间曲线显示出多个不同的阶段。在剂量为0.25-0.75mgTTX / kg体重的情况下,血药浓度-时间曲线下的面积(AUC)呈线性增加,并且总体清除率为2.06 +/- 0.17mL / min / kg体重。肝门静脉和肝静脉给药后的AUC极为相似(147 +/- 33对141 +/- 1ng.min / muL),表明肝首过效应可忽略不计。比较肝静脉和胃肠道给药后的AUCs(0.25mgTTX / kg体重)可知TTX的生物利用度为62%。直接注射入胃肠道后,AUCs没有显着增加(0.50对1.0mgTTX / kg体重)。在肝静脉,肝门静脉或胃肠道中以0.25mgTTX / kg体重的剂量服用时,肝脏中的TTX量占肝脏的84 +/- 6%,70 +/- 9%或49 +/- 17%分别应用的总TTX金额。这些结果表明,TTX通过饱和机制从胃肠道吸收到全身循环中,并最终在300min内在肝脏中积累。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号